Fortrea Holdings (FTRE) Other Non-Current Assets (2022 - 2026)

Fortrea Holdings (FTRE) reported Other Non-Current Assets of $86.1 million for Q1 2026, down 15.09% on a YoY basis from $101.4 million in Q1 2025, and up 6.56% quarter-over-quarter from $80.8 million in Q4 2025.

Fortrea Holdings (FTRE) Other Non-Current Assets (2022 - 2026) Analysis & Trends

Fortrea Holdings has reported Other Non-Current Assets for 5 years, with the latest figure at $86.1 million in Q1 2026.

  • For the quarter ending Q1 2026, Other Non-Current Assets fell 15.09% year-over-year to $86.1 million; the trailing twelve-month figure through Mar 2026 stood at $86.1 million (down 15.09% YoY), and the FY2025 full-year result was $80.8 million, down 21.86% from the prior year.
  • Other Non-Current Assets for Q1 2026 stood at $86.1 million, up from $80.8 million in the prior quarter.
  • The five-year high for Other Non-Current Assets was $103.4 million in Q4 2024, with the low at $54.3 million in Q4 2022.
  • Historically, Other Non-Current Assets has averaged $81.8 million across 5 years, with a median of $80.8 million in 2025.
  • Annual changes were most pronounced in 2024 — Other Non-Current Assets soared 48.35% — and 2025, when it fell 21.86%.
  • Fortrea Holdings' Other Non-Current Assets stood at $54.3 million in 2022, then rose by 28.36% to $69.7 million in 2023, then soared by 48.35% to $103.4 million in 2024, then slipped by 21.86% to $80.8 million in 2025, then climbed by 6.56% to $86.1 million in 2026.
  • The last three Other Non-Current Assets figures came in at $86.1 million (Q1 2026), $80.8 million (Q4 2025), and $74.2 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 289.41 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 12.40 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 60,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 1.26 Bn
9 Abivax 91.96 Bn 91.96 Bn - -
10 Fortrea Holdings 1.43 Bn 1.28 Bn 123.60 Mn 86.10 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 86.10 Mn
Dec 31, 2025 80.80 Mn
Sep 30, 2025 74.20 Mn
Jun 30, 2025 101.30 Mn
Mar 31, 2025 101.40 Mn
Dec 31, 2024 103.40 Mn
Mar 31, 2024 74.90 Mn
Dec 31, 2023 69.70 Mn
Sep 30, 2023 69.70 Mn
Jun 30, 2023 83.70 Mn
Dec 31, 2022 54.30 Mn